日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Liproxstatin-1 Attenuates Retinal Ischemia-Reperfusion Injury by Suppressing EGR1-Mediated Ferroptosis.

Liproxstatin-1 通过抑制 EGR1 介导的铁死亡来减轻视网膜缺血再灌注损伤。

期刊:Antioxidants
影响因子:6.6
doi:10.3390/antiox15030391
Huang Wei, Dong Yue, Zhou Xuan, Lin Huishan, Yao Jingwei, Wu Zhuoyi, Tam Weng Ian, Tan Yuheng, Zuo Chengguo, Lin Mingkai
TAT
EGR1
铁死亡
发表日期：2026
文献求助 收藏

Combination of HDAC inhibitor and PI3K inhibitor suppresses autophagy and induces apoptosis via cytoplasmic IκBα stabilization in p53-mutant diffuse large B-cell lymphoma.

HDAC 抑制剂和 PI3K 抑制剂的组合通过胞质 Iββ 稳定抑制自噬并诱导 p53 突变弥漫性大 B 细胞淋巴瘤细胞凋亡

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02756-7
Yao Jingwei, Li Mengqi, Jiang Yuelong, Yao Nanye, Liu Yating, Lv Liemei, Li Yuchen, Huang Jiewen, Zha Jie, Xu Bing
细胞生物学
P53
凋亡
自噬
发表日期：2025
文献求助 收藏

Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma.

在转化型滤泡性淋巴瘤的临床前模型中，维奈托克可赋予西达米德合成致死性

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-025-01878-0
Zhong Mengya, Pan Guangchao, Tan Jinshui, Yao Jingwei, Liu Yating, Huang Jiewen, Jiang Yuelong, Zhu Depeng, Zhao Jintao, Xu Bing, Zha Jie
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

DGKα inhibition enhances the antitumor effect of chiauranib on transformed follicular lymphoma.

DGKα抑制增强了chiauranib对转化型滤泡性淋巴瘤的抗肿瘤作用。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06636-z
Huang Jiewen, Zhong Mengya, Yao Jingwei, Pan Guangchao, Chen Qinwei, Liu Yating, Jiang Yuelong, Luo Yiming, Zha Jie, Xu Bing
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic implications of cGAS and STING gene expression in acute myeloid leukemia

cGAS和STING基因表达在急性髓系白血病中的预后意义

期刊:Experimental Biology and Medicine
影响因子:2.7
doi:10.3389/ebm.2024.10108
Chen, Qiuling; Hong, Yan; Chen, WeiFeng; Lin, Feng; Zeng, Jiawei; Huang, Yueting; Zhang, Li; Yao, Jingwei; Xu, Bing
白血病
STING
发表日期：2024
文献求助 收藏

Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer

全外显子组测序在下咽癌筛查和新突变鉴定中的应用价值

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-27273-w
Yao, Jingwei; Ding, Yubo; Liu, Xiong; Huang, Jialu; Zhang, Minghui; Zhang, Yu; Lv, Yufan; Xie, Zhuoyi; Zuo, Jianhong
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.

Orelabrutinib 和 venetoclax 通过干扰 PI3K/AKT 和 p38/MAPK 信号通路之间的串扰，协同诱导双重打击淋巴瘤细胞死亡

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-04473-5
Pan Guangchao, Zhong Mengya, Yao Jingwei, Tan Jinshui, Zheng Huijian, Jiang Yuelong, Tang Yuanfang, Zhou Hui, Qin Dongmei, Yu Xingxing, Liu Long, Li Zhifeng, Lin Zhijuan, Jiang Yirong, Xu Bing, Zha Jie
信号转导
细胞生物学
PI3K/Akt
发表日期：2023
文献求助 收藏

Research Progress and Direction of Novel Organelle-Migrasomes

新型细胞器-迁移体的研究进展与方向

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15010134
Zhang, Yu; Zhang, Minghui; Xie, Zhuoyi; Ding, Yubo; Huang, Jialu; Yao, Jingwei; Lv, Yufan; Zuo, Jianhong
细胞生物学
发表日期：2022
文献求助 收藏

The effect of surgery plus intensity-modulated radiotherapy on treatment in laryngeal cancer: A clinical retrospective study

手术联合调强放射治疗对喉癌治疗效果的影响：一项临床回顾性研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-021-03637-z
Deng, Kun; Yao, Jingwei; Zeng, Shuqing; Wen, Meiling; Huang, Jialu; Zhu, Tao; Liu, Shanyan; Zuo, Jianhong
喉癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma

ctDNA测序在肝细胞癌中的潜力、分析和前景

期刊:PeerJ
影响因子:2.4
doi:10.7717/peerj.13473
Ding, Yubo; Yao, Jingwei; Wen, Meiling; Liu, Xiong; Huang, Jialu; Zhang, Minghui; Zhang, Yu; Lv, Yufan; Xie, Zhuoyi; Zuo, JianHong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏